Question 1

What is the ESG rating for MRK?

Accepted Answer

Merck & Co. Inc. has the following ESG ratings: MSCI ESG Rating: A, Sustainalytics ESG Risk: 18.8 (Low Risk), ESG Enterprise Score: 70/100 (Proprietary).

Question 2

What are the main strengths of investing in MRK?

Accepted Answer

The main strengths of investing in Merck & Co. Inc. include: Billions of doses donated for river blindness eradication, Carbon neutrality target by 2025 ahead of peers, High Access to Medicine Index rankings.

Question 3

What are the potential drawbacks of investing in MRK?

Accepted Answer

Potential drawbacks of investing in Merck & Co. Inc. include: Keytruda pricing raises affordability concerns, Fighting Medicare price negotiations criticized, Vioxx legacy reminds of safety oversight importance.

Question 4

What are the key financial metrics for MRK?

Accepted Answer

Key financial metrics for Merck & Co. Inc. include: Market Cap: $6.17 billion, Current Price: $282.59, Dividend Yield: 4.03%.

Merck & Co. Inc.

Detailed View

MRK

ESG Ratings